I am a
Home I AM A Search Login

Papers of the Week

2022 Jun 25

Curr Pain Headache Rep

Cardiovascular Disease and Migraine: Are the New Treatments Safe?


Robblee J, Harvey LK
Curr Pain Headache Rep. 2022 Jun 25.
PMID: 35751798.


The authors present data on cardiovascular safety for the new acute and preventive migraine treatments including ditans, gepants, and calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) alongside older medications like triptans and ergotamines.